AMB-FUBINACA
id:
amb-fubinaca-180-15449782
title:
AMB-FUBINACA
text:
AMB-FUBINACA (also known as FUB-AMB and MMB-FUBINACA) is an indazole-based synthetic cannabinoid that is a potent agonist for the cannabinoid receptors, with Ki values of 10.04 nM at CB1 and 0.786 nM at CB2 and EC50 values of 0.5433 nM at CB1 and 0.1278 nM at CB2, and has been sold online as a designer drug. It was originally developed by Pfizer which described the compound in a patent in 2009, but was later abandoned and never tested on humans. AMB-FUBINACA was the most common synthetic cannabi
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/AMB-FUBINACA
date created:
2015-07-21T13:13:08Z
date modified:
2024-09-05T13:51:18Z
main entity:
{"identifier":"Q20707530","url":"https://www.wikidata.org/entity/Q20707530"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b9/AMB-FUBINACA.svg","width":1285,"height":1796}
fields total:
13
integrity:
16